Atypical femoral fracture in a patient treated with denosumab

Atypical fracture of the femur in a patient using denosumab – a case report

(2014) Jörg Schilcher et al.   Acta Orthopaedica

Atypical femoral fractures bilaterally in a patient receiving denosumab

(2013) Efstathios Drampalos et al.   Acta Orthopaedica

Proposed pathogenesis for atypical femoral fractures: Lessons from materials research

(2013) B. Ettinger et al.   BONE

A Case of an Unusual Subtrochanteric Fracture in a Patient Receiving Denosumab

(2013) Rodis Paparodis et al.   Endocrine Practice

Denosumab in osteoporosis

(2013) Dima L Diab et al.   Expert Opinion On Drug Safety

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

(2013) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

(2013) Henry G. Bone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy

(2012) Cherie Ying Chiang et al.   BONE

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE